Aynechi Tiba

Aynechi Tiba serves as a Director at MBX Biosciences, Inc., where he is involved in strategic decisions within the healthcare sector. His recent insider trading activity, tracked through SEC Form 4 filings, reveals a total of three public disclosures from June 6, 2025, to June 5, 2026, primarily focused on MBX Biosciences (MBX) and Spruce Biosciences (SPRB). The disclosed amounts range from $386.4K to $189.8K, with the largest recorded move being a grant or exercise valued at approximately $386.4K on June 5, 2026.